Dr. Martin Paulus has published a viewpoint article in JAMA Psychiatry that highlights the difficulties of making neuroscience useful for clinical psychiatry and advocates for a risk-prediction model in the development of impactful biological psychiatry to help patients now. LIBR's Tulsa 1000 study is based on this premise of making an impact on everyday psychiatric practice.